Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Astrazeneca Plc (NQ: AZN )

52.27 +0.64 (+1.24%)
Official Closing Price Updated: 7:55 PM EDT, Apr 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Astrazeneca Plc

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips So what did the stock market do today? It seems investors are uneasy with rising Covid-19 cases and an uncertain reopening rally. The post... 
Tags NYSE:JNJ,NASDAQ:AZN,NASDAQ:UAL,NASDAQ:AAL,NYSE:DAL,NYSE:CCL,NASDAQ:COIN,CCC:DOGE/USD,NASDAQ:NFLX AAL COIN
From InvestorPlace
European Drug Regulator Slaps Safety Warning On J&J Jab Due To Blood-Clot Links
While Europe grapples with its own vaccine safety scandal, the EMA, the same EU pharma regulator that has insisted that the AstraZeneca-Oxford jab's benefits far outweigh its risk, has just poured cold... 
Tags Pharma/Biotech Stocks / Equities Market News
From Blogs - TalkMarkets
EMA Finds Potential Blood Clot Link With JNJ COVID-19 Shot, Adds Safety Warning
The European Medicines Agency’s (EMA) safety committee said that theJohnson & Johnson’s(NYSE:JNJ) ... 
Tags Market News AZN Health Care
From Benzinga
Global tally of COVID-19 cases top 142 million as India’s surging cases raise the alarm
The number of confirmed cases of the coronavirus-borne illness COVID-19 climbed above 142 million on Tuesday, and India remained a hot spot, recording more than 250,000 new infections and over 1,700... 
Tags UK:AZN AZN
From MarketWatch
Ocugen's Partner Bharat Biotech Ramping Manufacturing To Produce 700M COVID-19 Vaccine Doses Annually
India's Bharat Biotech has announced COVAXIN capacity expansion to support vaccination campaigns in India and globally amid ... 
Tags Small Cap India AZN
From Benzinga
I Got My Jab, Here's What Happened, And A Look At Vaccine Stocks
COVID-19 vaccine revenues and profits may be lowballed right now. Ultimately, the underlying companies have very strong business prospects independent of their COVID operations. 
Tags Stocks / Equities Healthcare Pharma/Biotech
From Blogs - TalkMarkets
Robots
Teva is suffering from fear of the legal risks of its opioid misselling which is overriding good news of its newer drugs. 
Tags Healthcare Technology Stocks / Equities
From Blogs - TalkMarkets
Serum Institute Nears $400M Funding From Indian Government To Boost COVID-19 Vaccine Manufacturing Capacity
Serum Institute of India (SII), which has been under pressure, had called on the Indian government for financial support to boost the ... 
Tags News General COVID/19 Vaccine
From Benzinga
Why Emergent BioSolutions Stock Is Tumbling Today
The company has halted production of COVID-19 vaccines at its Baltimore facility as an FDA inspection moves forward. 
Tags EBS JNJ Market News
From Motley Fool
CytoSorbents To Start US Study With CytoSorb For Ticagrelor Removal
The FDA hassigned off conditional approvalfor the STAR-T study to assessCytoSorbents ... 
Tags Biotech Health Care Briefs
From Benzinga
Here’s What $1,000 Invested In Vaccine Stocks Would Be Worth Now
It’s often said that with every crisis comes great opportunity. While such catastrophes do create upheaval and uncertainty in financial markets, they can also lead to new opportunities for investors,... 
Tags Market News Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
JNJ COVID-19 Vaccine Could Return This Week With Warning, Says Anthony Fauci
The U.S. is likely to resumeJohnson & Johnson’s(NYSE:JNJ) COVID-19 vaccine in the coming week, possibly ... 
Tags Biotech FDA Briefs
From Benzinga
Here’s what we know about COVID-19 vaccine side effects in women
'The more we talk about it, the more we’re validating the symptoms that people are having.' 
Tags BNTX GOOG AZN
From MarketWatch
J&J vaccine was paused due to fear blood clots could be mistreated
U.S. health authorities came close to simply warning about a blood-clotting risk from Johnson & Johnson’s COVID-19 vaccine, but decided to recommend pausing use out of concern doctors would improperly... 
Tags AZN JNJ
From MarketWatch
The Virus, Vaccine, And Economic Velocity
The fact that neither the dollar nor US interest rates rose after the stronger-than-expected March CPI may be saying something about market sentiment and positioning. It lends credence to the idea that... 
Tags Financial Market News Bonds
From Blogs - TalkMarkets
AstraZeneca's Vaccine Data Is Still Good Enough for U.S. Authorization
An Emergency Use Authorization from the FDA should happen soon. 
Tags Market News AZN NVAX
From Motley Fool
1 Cancer Stock to Buy and Hold for the Next Decade
Blueprint Medicines is setting itself up to become the leader in precision oncology. 
Tags Market News AZN IBB
From Motley Fool
Currency Manipulation
London's FTSE 100 index today rose over 7000 for the first time in 14 months. It hit 7019.53. 
Tags Stocks / Equities Market News
From Blogs - TalkMarkets
Why comparing blood clot risks from COVID-19 vaccines and birth control pills doesn’t work
Doctors say they are different kinds of clots --- and the coronavirus poses a greater risk than the vaccines 
Tags AZN JNJ
From MarketWatch
Dow Jones Rally Led By Cisco Systems; Moderna Soars 7%, Tops Nasdaq 100 Performance
The Dow Jones was up modestly in afternoon trading, poised for its fourth straight weekly gain. Cisco Systems outperformed, helped by an analyst upgrade. 
From Investor's Business Daily
WHO says global COVID-19 cases nearly doubled in last two months, making vaccine drive more urgent than ever
The World Health Organization warned Friday that the global tally of confirmed cases of the coronavirus-borne illness COVID-19 has almost doubled in the last two months, and is now approaching the... 
Tags LLY UK:AZN AZN
From MarketWatch
J&J privately asked rival COVID-19 vaccine makers to probe clotting risks
Johnson & Johnson privately reached out to Covid-19 vaccine rivals to ask them to join an effort to study the risks of blood clots and speak with one voice about safety, but Pfizer Inc. and Moderna... 
Tags AZN Pharmaceuticals MRNA
From MarketWatch
Norway delays decision to ditch AstraZeneca vaccine, warning it could impact J&J rollout
The Norwegian government said it needs more time to decide whether to restart the use of AstraZeneca's COVID-19 vaccine, or permanently remove it from the country's immunization program. 
Tags UK:AZN JNJ AZN
From MarketWatch
European stocks inch toward fresh records as Chinese data cheer investors, while U.S. futures hold steady
European stocks are climbing after China follows strong U.S. growth with blowout data of its own. The Stoxx 600 and German DAX are headed for fresh record closes. 
Tags XE:HEI GBPUSD YM00
From MarketWatch
Why Fauci Thinks Getting Johnson & Johnson COVID-19 Vaccine 'Back On Track' Soon Is Crucial
White House Chief Medical Advisor Dr. Anthony Fauci believes U.S. regulators will make a quick decision to lift the pause on ... 
Tags Covid/19 Biotech Market News
From Benzinga
Happy News Day
The stock markets are in clover because March retail sales hit 9.8% according to the Department of Commerce. 
Tags Market News Stocks / Equities
From Blogs - TalkMarkets
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips So what did the stock market do today? Investors were closely watching Dogecoin price predictions and fretting about QS stock. The post... 
Tags DOGE/USD MRNA PFE
From InvestorPlace
How J&J's Coronavirus Vaccine Fiasco Could Benefit Novavax And Others
The extended pause for Johnson & Johnson's coronavirus vaccine in the U.S. could bolster vaccine stocks Pfizer, Moderna and Novavax, experts say. And the question of herd immunity looms. 
From Investor's Business Daily
Getting COVID creates far higher risk of rare blood clots than vaccines, Oxford study finds
A new study from researchers at Oxford University has found that people who contract COVID-19 are at far higher risk of developing blood clots than people who receive COVID-19 vaccines, further... 
Tags BNTX AZN MRNA
From MarketWatch
How Soon Will Novavax File for Emergency Use Authorization for Its COVID Vaccine?
European filings will likely come sooner than the biotech's U.S. submission. 
Tags NVAX AZN Market News
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback